Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gulsah Malgir"'
Autor:
Jesus Paez-Mayorga, Jocelyn Nikita Campa-Carranza, Simone Capuani, Nathanael Hernandez, Hsuan-Chen Liu, Corrine Ying Xuan Chua, Fernanda Paola Pons-Faudoa, Gulsah Malgir, Bella Alvarez, Jean A. Niles, Lissenya B. Argueta, Kathryn A. Shelton, Sarah Kezar, Pramod N. Nehete, Dora M. Berman, Melissa A. Willman, Xian C. Li, Camillo Ricordi, Joan E. Nichols, A. Osama Gaber, Norma S. Kenyon, Alessandro Grattoni
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-20 (2022)
Islet transplantation for type 1 diabetes management is hindered by the life-long need for immunosuppressive medications. Here, the authors report an islet encapsulation device with local anti-rejection drug release that achieves long-term diabetes r
Externí odkaz:
https://doaj.org/article/ef6eb5e65db74c5a8927a7416c908e0b
Publikováno v:
Bioengineering & Translational Medicine, Vol 7, Iss 3, Pp n/a-n/a (2022)
Abstract Mitigating the foreign body response (FBR) to implantable medical devices (IMDs) is critical for successful long‐term clinical deployment. The FBR is an inevitable immunological reaction to IMDs, resulting in inflammation and subsequent fi
Externí odkaz:
https://doaj.org/article/e302435dfdb74eb387f6aa83fc542b42
Autor:
Jesus Paez-Mayorga, Jocelyn Campa-Carranza, Simone Capuani, Nathanael Hernandez, Ying Chua, Fernanda Pons-Faudoa, Gulsah Malgir, Bella Alvarez, Jean Niles, Kathryn Shelton, Sarah Kezar, Pramod Nehete, Dora Berman-Weinberg, Xian Li, Camillo Ricordi, Joan Nichols, Ahmed Gaber, Norma Kenyon, Alessandro Grattoni
Pancreatic islet transplantation efficacy for type 1 diabetes (T1D) management is limited by hypoxia-related graft attrition and need for systemic immunosuppression. To overcome these challenges, we developed the Neovascularized Implantable Cell Homi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c2f8afeefe24c63c5459f67404fe734
https://doi.org/10.21203/rs.3.rs-1285406/v1
https://doi.org/10.21203/rs.3.rs-1285406/v1
Publikováno v:
Bioengineeringtranslational medicine. 7(3)
Mitigating the foreign body response (FBR) to implantable medical devices (IMDs) is critical for successful long-term clinical deployment. The FBR is an inevitable immunological reaction to IMDs, resulting in inflammation and subsequent fibrotic enca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc0d8ca2eb9fd254d7088fc2427cc9fe
https://pubmed.ncbi.nlm.nih.gov/36176611
https://pubmed.ncbi.nlm.nih.gov/36176611
Autor:
Peter L. Anderson, Alessandro Grattoni, Kathryn A. Shelton, Corrine Ying Xuan Chua, Antons Sizovs, Gulsah Malgir, Pramod N. Nehete, Lane R. Bushman, K. Jagannadha Sastry, Fernanda P. Pons-Faudoa
Publikováno v:
Int J Pharm
Long-acting (LA) pre-exposure prophylaxis (PrEP) for HIV prevention is poised to address non-adherence and implementation challenges by alleviating the burden of user-dependent dosing. Due to its potency, tenofovir alafenamide (TAF) is a viable candi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::861f4e908d39e0d9646d6a363551f626
https://doi.org/10.1016/j.ijpharm.2020.119623
https://doi.org/10.1016/j.ijpharm.2020.119623